Quinolone Resistance of Salmonella Enterica Serovar Virchow Isolates from Humans and Poultry in Israel: Evidence for Clonal Expansion

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2007 Jun 29

PMID 17596371

Citations 10

Authors

Hadas Solnik-Isaac

Miriam Weinberger

Mina Tabak

Alon Ben-David

Dina Shachar

Sima Yaron

Affiliations

Soon will be listed here.

Abstract

Salmonella enterica serovar Virchow is highly prevalent in humans and farm animals in Israel. In addition to high rates of resistance to multiple antibiotics, this serovar exhibits a high incidence of resistance to nalidixic acid. More than 90% of Salmonella serovar Virchow isolates of human and poultry origin obtained from 1997 to 2004 were resistant to nalidixic acid (MIC > or = 128 microg/ml), with reduced susceptibility to ciprofloxacin (MIC between 0.125 and 0.250 microg/ml). Most isolates belonged to two predominant, closely related pulsed-field gel electrophoresis image types. Investigation of the mechanisms of quinolone resistance revealed that this pathogen probably emerged from a parental clone that overproduced the AcrAB efflux pump and had a single point mutation in gyrA leading to the Asp87Tyr substitution. The close resemblance between human and poultry isolates points to poultry as a likely source of Salmonella serovar Virchow in the food chain.

Citing Articles

The activity of BcsZ of Typhimurium and its role in -plants interactions.

Fratty I, Shachar D, Katsman M, Yaron S Front Cell Infect Microbiol. 2022; 12:967796.

PMID: 36081768 PMC: 9445439. DOI: 10.3389/fcimb.2022.967796.

Quinolone resistant Salmonella species isolated from pediatric patients with diarrhea in central Iran.

Abbasi E, Ghaznavi-Rad E BMC Gastroenterol. 2021; 21(1):140.

PMID: 33784974 PMC: 8010990. DOI: 10.1186/s12876-021-01719-3.

Increasing incidence of invasive nontyphoidal Salmonella infections in Queensland, Australia, 2007-2016.

Parisi A, Crump J, Stafford R, Glass K, Howden B, Kirk M PLoS Negl Trop Dis. 2019; 13(3):e0007187.

PMID: 30883544 PMC: 6422252. DOI: 10.1371/journal.pntd.0007187.

Adaptation of Salmonella enterica Serovar Senftenberg to Linalool and Its Association with Antibiotic Resistance and Environmental Persistence.

Kalily E, Hollander A, Korin B, Cymerman I, Yaron S Appl Environ Microbiol. 2017; 83(10.

PMID: 28258149 PMC: 5411494. DOI: 10.1128/AEM.03398-16.

Salmonella Virchow Infection of the Chicken Elicits Cellular and Humoral Systemic and Mucosal Responses, but Limited Protection to Homologous or Heterologous Re-Challenge.

Salisbury A, Leeming G, Nikolaou G, Kipar A, Wigley P Front Vet Sci. 2015; 1:6.

PMID: 26664914 PMC: 4668861. DOI: 10.3389/fvets.2014.00006.

References

Choi S, Woo J, Lee J, Park S, Choo E, Kwak Y . Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. J Antimicrob Chemother. 2005; 56(6):1111-4. DOI: 10.1093/jac/dki369. View

Ben-Barak Z, Streckel W, Yaron S, Cohen S, Prager R, Tschape H . The expression of the virulence-associated effector protein gene avrA is dependent on a Salmonella enterica-specific regulatory function. Int J Med Microbiol. 2005; 296(1):25-38. DOI: 10.1016/j.ijmm.2005.08.004. View

Gay K, Robicsek A, Strahilevitz J, Park C, Jacoby G, Barrett T . Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin Infect Dis. 2006; 43(3):297-304. DOI: 10.1086/505397. View

Giraud E, Baucheron S, Cloeckaert A . Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect. 2006; 8(7):1937-44. DOI: 10.1016/j.micinf.2005.12.025. View

Bertrand S, Weill F, Cloeckaert A, Vrints M, Mairiaux E, Praud K . Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol. 2006; 44(8):2897-903. PMC: 1594617. DOI: 10.1128/JCM.02549-05. View

Weinberger M, Solnik-Isaac H, Shachar D, Reisfeld A, Valinsky L, Andorn N . Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel. Clin Microbiol Infect. 2006; 12(10):999-1005. DOI: 10.1111/j.1469-0691.2006.01466.x. View

Robicsek A, Jacoby G, Hooper D . The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10):629-40. DOI: 10.1016/S1473-3099(06)70599-0. View

Bennett C, Dalton C, Beers-Deeble M, Milazzo A, Kraa E, Davos D . Fresh garlic: a possible vehicle for Salmonella Virchow. Epidemiol Infect. 2004; 131(3):1041-8. PMC: 2870050. DOI: 10.1017/s0950268803001158. View

Casin I, Breuil J, Darchis J, Guelpa C, Collatz E . Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. Emerg Infect Dis. 2004; 9(11):1455-7. PMC: 3035553. DOI: 10.3201/eid0911.030317. View

10.

Ling J, Chan E, Lam A, Cheng A . Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother. 2003; 47(11):3567-73. PMC: 253778. DOI: 10.1128/AAC.47.11.3567-3573.2003. View

11.

Paulsen I . Multidrug efflux pumps and resistance: regulation and evolution. Curr Opin Microbiol. 2003; 6(5):446-51. DOI: 10.1016/j.mib.2003.08.005. View

12.

Hopkins K, Arnold C, Threlfall E . Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology. J Microbiol Methods. 2006; 68(1):163-71. DOI: 10.1016/j.mimet.2006.07.006. View

13.

Threlfall E, Fisher I, Berghold C, Gerner-Smidt P, Tschape H, Cormican M . Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill. 2003; 8(2):41-5. DOI: 10.2807/esm.08.02.00400-en. View

14.

Tibbetts R, Long Lin T, Wu C . Phenotypic evidence for inducible multiple antimicrobial resistance in Salmonella choleraesuis. FEMS Microbiol Lett. 2003; 218(2):333-8. DOI: 10.1016/S0378-1097(02)01179-5. View

15.

Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A . The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist. 2003; 8(4):281-9. DOI: 10.1089/10766290260469543. View

16.

Eaves D, Liebana E, Woodward M, Piddock L . Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J Clin Microbiol. 2002; 40(11):4121-5. PMC: 139672. DOI: 10.1128/JCM.40.11.4121-4125.2002. View

17.

Hirose K, Hashimoto A, Tamura K, Kawamura Y, Ezaki T, Sagara H . DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob Agents Chemother. 2002; 46(10):3249-52. PMC: 128770. DOI: 10.1128/AAC.46.10.3249-3252.2002. View

18.

Randall L, Woodward M . The multiple antibiotic resistance (mar) locus and its significance. Res Vet Sci. 2002; 72(2):87-93. DOI: 10.1053/rvsc.2001.0537. View

19.

Levy S . Active efflux, a common mechanism for biocide and antibiotic resistance. J Appl Microbiol. 2002; 92 Suppl:65S-71S. View

20.

Helms M, Vastrup P, Gerner-Smidt P, Molbak K . Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis. 2002; 8(5):490-5. PMC: 2732497. DOI: 10.3201/eid0805.010267. View